Insomnia in Postmenopausal Women: How to Approach and Treat It?
Insomnia is one of the major complaints of menopausal women with advancing age and may be complexly related to a variety of causes. However, there is still a lack of standards on the general approach and treatment for insomnia in menopausal women. The aim of this review is to summarize recent pathog...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-01-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/13/2/428 |
| _version_ | 1797339702147153920 |
|---|---|
| author | Gyun-Ho Jeon |
| author_facet | Gyun-Ho Jeon |
| author_sort | Gyun-Ho Jeon |
| collection | DOAJ |
| description | Insomnia is one of the major complaints of menopausal women with advancing age and may be complexly related to a variety of causes. However, there is still a lack of standards on the general approach and treatment for insomnia in menopausal women. The aim of this review is to summarize recent pathogenic theories of sleep disturbance in the menopausal period and discuss the approach and management of insomnia in postmenopausal women. Sleep disturbances in menopausal women may be associated with physical and psychiatric factors and other comorbid diseases. Careful history taking and multidisciplinary physical and psychosocial evaluation are necessary and, in particular, comorbidities related to sleep disorders, such as obstructive sleep apnea, must be taken into consideration. A unique aspect of insomnia in postmenopausal women is that menopausal symptoms due to hormonal decline can be closely related to sleep disturbances. Therefore, menopausal hormone therapy (MHT) should be considered as the treatment of choice among pharmacological treatments following cognitive behavioral therapy, which is suggested as the first-line treatment in the general population insomnia treatment guidelines. Additionally, melatonin and 5HT-based drugs, which have fewer side effects, along with MHT should be preferentially recommended in menopausal women. |
| first_indexed | 2024-03-08T09:52:12Z |
| format | Article |
| id | doaj.art-b26cc11e01a3469183dabc663bd3d93d |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-08T09:52:12Z |
| publishDate | 2024-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-b26cc11e01a3469183dabc663bd3d93d2024-01-29T14:01:41ZengMDPI AGJournal of Clinical Medicine2077-03832024-01-0113242810.3390/jcm13020428Insomnia in Postmenopausal Women: How to Approach and Treat It?Gyun-Ho Jeon0Department of Obstetrics and Gynecology, Haeundae Paik Hospital, Inje University School of Medicine, Busan 48108, Republic of KoreaInsomnia is one of the major complaints of menopausal women with advancing age and may be complexly related to a variety of causes. However, there is still a lack of standards on the general approach and treatment for insomnia in menopausal women. The aim of this review is to summarize recent pathogenic theories of sleep disturbance in the menopausal period and discuss the approach and management of insomnia in postmenopausal women. Sleep disturbances in menopausal women may be associated with physical and psychiatric factors and other comorbid diseases. Careful history taking and multidisciplinary physical and psychosocial evaluation are necessary and, in particular, comorbidities related to sleep disorders, such as obstructive sleep apnea, must be taken into consideration. A unique aspect of insomnia in postmenopausal women is that menopausal symptoms due to hormonal decline can be closely related to sleep disturbances. Therefore, menopausal hormone therapy (MHT) should be considered as the treatment of choice among pharmacological treatments following cognitive behavioral therapy, which is suggested as the first-line treatment in the general population insomnia treatment guidelines. Additionally, melatonin and 5HT-based drugs, which have fewer side effects, along with MHT should be preferentially recommended in menopausal women.https://www.mdpi.com/2077-0383/13/2/428hot flushesinsomniamenopausesleep disordermenopausal hormonal therapy |
| spellingShingle | Gyun-Ho Jeon Insomnia in Postmenopausal Women: How to Approach and Treat It? Journal of Clinical Medicine hot flushes insomnia menopause sleep disorder menopausal hormonal therapy |
| title | Insomnia in Postmenopausal Women: How to Approach and Treat It? |
| title_full | Insomnia in Postmenopausal Women: How to Approach and Treat It? |
| title_fullStr | Insomnia in Postmenopausal Women: How to Approach and Treat It? |
| title_full_unstemmed | Insomnia in Postmenopausal Women: How to Approach and Treat It? |
| title_short | Insomnia in Postmenopausal Women: How to Approach and Treat It? |
| title_sort | insomnia in postmenopausal women how to approach and treat it |
| topic | hot flushes insomnia menopause sleep disorder menopausal hormonal therapy |
| url | https://www.mdpi.com/2077-0383/13/2/428 |
| work_keys_str_mv | AT gyunhojeon insomniainpostmenopausalwomenhowtoapproachandtreatit |